Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications—reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study

TY - JOUR

T1 - Letter

T2 - risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications—reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study

AU - the PREPARE-IBD Study Group

AU - Lamb, Christopher A.

AU - Sebastian, Shaji

AU - Kent, Alexandra J.

AU - Segal, Jonathan P.

AU - Gonzalez, Haidee A.

AU - Brookes, Matthew J.

AU - Mehta, Shameer J.

AU - Subramanian, Sreedhar

AU - Bhala, Neeraj

AU - Hicks, Lucy C.

AU - Conley, Thomas E.

AU - Patel, Kamal V.

AU - Walker, Gareth J.

AU - Kennedy, Nicholas A.

PY - 2021/6

Y1 - 2021/6

UR - https://www.scopus.com/pages/publications/85105444367

U2 - 10.1111/apt.16349

DO - 10.1111/apt.16349

M3 - Letter

C2 - 33961708

AN - SCOPUS:85105444367

SN - 0269-2813

VL - 53

SP - 1236

EP - 1240

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

IS - 11

ER -